Latest Breaking News On - Open market sale agreement - Page 4 : comparemela.com

Form 10-K Milestone Pharmaceutical For: Dec 31

Sangamo Therapeutics : Open Market Sale Agreement - Form 8-K

Sgmo-20230307 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 . | March 7, 2023

Purple Biotech Ltd.: Purple Biotech Reports Fourth Quarter and Full-Year 2022 Financial Results

Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. 08, 2023 (GLOBE NEWSWIRE) Purple Biotech Ltd. ("Purple

Purple Biotech Reports Fourth Quarter and Full-Year 2022

Expands pipeline with acquisition of new tri-specific antibodies Data readouts for two lead clinical programs expected in 2023 REHOVOT, Israel, Feb. .

MicroStrategy Announces Fourth Quarter 2022 Financial Results

MicroStrategy® Incorporated , the largest independent publicly-traded business intelligence company, today announced financial results for the three-month period ended December 31, 2022. | February 2, 2023